Rebecca J Brown, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
12
12
4
N/A
0
47
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+3 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (12)
Showing 10 of 12 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Worked with same sponsors:
David s Ludwig, MD, PhD
Boston Children's Hospital
Shared therapeutic areas:
Worked with same sponsors:
Samuel Klein, MD
Washington University School of Medicine
Shared therapeutic areas:
Worked with same sponsors:
Ali MA Ismail, lecturer
Cairo University
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
ali ismail, lecturer
Cairo University
Shared therapeutic areas:
David Crowley, MD
KGK Science Inc.
Shared therapeutic areas:
Timothy Bailey, MD
AMCR Institute
Shared therapeutic areas:
Worked with same sponsors:
Gisèle Pickering
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (12)
Showing 12 of 12 trials
Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)
Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance
Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy
Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy
Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy
Metabolic Effects of Non-Nutritive Sweeteners
Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance
Genetic Studies of Insulin and Diabetes
Short-term Effects of Leptin in People With Lipodystrophy
Thyroid Hormone to Induce Non-Insulin Mediated Glucose Disposal in People With Insulin Receptor Mutations
Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label Extension
Effects of Meal Macronutrients on Postprandial Lipids
All 12 trials loaded